Tubular cell-enriched subpopulation of primary renal cells improves survival and augments kidney function in rodent model of chronic kidney disease

American Journal of Physiology - Renal Physiology

Volumn 299, Issue 5, 2010, Pages

  Kelley, Rusty ^a   Werdin, Eric S ^a   Bruce, Andrew T ^a   Choudhury, Sumana ^a   Wallace, Shay M ^a   Ilagan, Roger M ^a   Cox, Bryan R ^a   Tatsumi Ficht, Patricia ^a   Rivera, Elias A ^a   Spencer, Thomas ^a   Rapoport, H Scott ^a   Wagner, Belinda J ^a   Guthrie, Kelly ^a   Jayo, Manuel J ^a   Bertram, Timothy A ^a   Presnell, Sharon C ^a  

^a Science and Technology ^*  (United States)

Author keywords

Regeneration; Stabilization

Indexed keywords

CREATININE; FIBRONECTIN; NITROGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA1; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SUBPOPULATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EXTRACELLULAR MATRIX; KIDNEY CELL; KIDNEY FUNCTION; KIDNEY TUBULE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; UREA NITROGEN BLOOD LEVEL;

EID: 78349240650     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00221.2010     Document Type: Article

References (46)

1. Aboushwareb T, Egydio F, Straker L, Gyabaah K, Atala A, Yoo JJ. Erythropoietin producing cells for potential cell therapy. World J Urol 26: 295-300, 2008.
2. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 331: 1286-1292, 1994.
3. Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol Renal Fluid Electrolyte Physiol 249: F324-F337, 1985.
4. Caruso-Neves C, Kwon SH, Guggino WB. Albumin endocytosis in proximal tubule cells is modulated by angiotensin II through an AT2 receptor-mediated protein kinase B activation. Proc Natl Acad Sci USA 102: 17513-17518, 2005.
5. Chade AR, Zhu X, Lavi R, Krier JD, Pislaru S, Simari RD, Napoli C, Lerman A, Lerman LO. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 119: 547-557, 2009.
6. Choi S, Park M, Kim J, Hwang S, Park S, Lee Y. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev 18: 521-529, 2009.
7. DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, Albelda SM. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151: 671-677, 1997.
8. Eddy AA, Fogo AB. Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. J Am Soc Nephrol 17: 2999-3012, 2006.
9. Eliopoulos N, Gagnon RF, Francois M, Galipeau J. Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure. J Am Soc Nephrol 17: 1576-1584, 2006.
10. Guo JK, Cantley LG. Cellular maintenance and repair of the kidney. Annu Rev Physiol 72: 357-376, 2010.
11. Held PK, Al-Dhalimy M, Willenbring H, Akkari Y, Jiang S, Torimaru Y, Olson S, Fleming WH, Finegold M, Grompe M. In vivo genetic selection of renal proximal tubules. Mol Ther 13: 49-58, 2006. (Pubitemid 41763482)
12. Hercz G. Regulation of bone remodeling: impact of novel therapies. Semin Dial 14: 55-60, 2001.
13. Humes HD, Lake EW, Liu S. Renal tubule cell repair following acute renal injury. Miner Electrolyte Metab 21: 353-365, 1995.
14. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Am J Pathol 141: 1381-1396, 1992.
15. Joraku A, Stern KA, Atala A, Yoo JJ. In vitro generation of three-dimensional renal structures. Methods 47: 129-133, 2009.
16. Kakinoki R, Bishop AT, Tu YK, Matsui N. Detection of the proliferated donor cells in bone grafts in rats, using a PCR for a Y-chromosome-specific gene. J Orthop Sci 7: 252-257, 2002.
17. Kaufman JM, DiMeola HJ, Siegel NJ, Lytton B, Kashgarian M, Hayslett JP. Compensatory adaptation of structure and function following progressive renal ablation. Kidney Int 6: 10-17, 1974.
18. Kim SS, Park HJ, Han J, Gwak SJ, Park MH, Song KW, Rhee YH, Min Chung H, Kim BS. Improvement of kidney failure with fetal kidney precursor cell transplantation. Transplantation 83: 1249-1258, 2007.
19. Kobayashi T, Terada Y, Kuwana H, Tanaka H, Okado T, Kuwahara M, Tohda S, Sakano S, Sasaki S. Expression and function of the Delta-1/Notch-2/Hes-1 pathway during experimental acute kidney injury. Kidney Int 73: 1240-1250, 2008.
20. Kreisberg JI, Pitts AM, Pretlow TG. Separation of proximal tubule cells from suspensions of rat kidney cells in density gradients of Ficoll in tissue culture medium. Am J Pathol 86: 591-602, 1977.
21. Lin F, Moran A, Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 115: 1756-1764, 2005.
22. Mazzinghi B, Ronconi E, Lazzeri E, Sagrinati C, Ballerini L, Angelotti ML, Parente E, Mancina R, Netti GS, Becherucci F, Gacci M, Carini M, Gesualdo L, Rotondi M, Maggi E, Lasagni L, Serio M, Romagnani S, Romagnani P. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med 205: 479-490, 2008.
23. Nakamura S, Nakamura I, Ma L, Vaughan DE, Fogo AB. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo. Kidney Int 58: 251-259, 2000.
24. Nelson WJ, Shore EM, Wang AZ, Hammerton RW. Identification of a membrane-cytoskeletal complex containing the cell adhesion molecule uvomorulin (E-cadherin), ankyrin, and fodrin in Madin-Darby canine kidney epithelial cells. J Cell Biol 110: 349-357, 1990.
25. Oosterwijk E, Van Muijen GN, Oosterwijk-Wakka JC, Warnaar SO. Expression of intermediate-sized filaments in developing and adult human kidney and in renal cell carcinoma. J Histochem Cytochem 38: 385-392, 1990.
26. Ormrod D, Miller T. Experimental uremia. Description of a model producing varying degrees of stable uremia. Nephron 26: 249-254, 1980.
27. Patschan D, Krupincza K, Patschan S, Zhang Z, Hamby C, Goligorsky MS. Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioning. Am J Physiol Renal Physiol 291: F176-F185, 2006.
28. Peterson DG, Stack SM, Healy JL, Donohoe BS, Anderson LK. The relationship between synaptonemal complex length and genome size in four vertebrate classes (Osteicthyes, Reptilia, Aves, Mammalia). Chromosome Res 2: 153-162, 1994.
29. Platt R, Roscoe MH, Smith FW. Experimental renal failure. Clin Sci (Lond) 11: 217-231, 1952.
30. Powe NR, Plantinga L, Saran R. Public health surveillance of CKD: principles, steps, and challenges. Am J Kidney Dis 53: S37-S45, 2009.
31. Prodromidi EI, Poulsom R, Jeffery R, Roufosse CA, Pollard PJ, Pusey CD, Cook HT. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells 24: 2448-2455, 2006.
32. Ritz E. The clinical management of hyperphosphatemia. J Nephrol 18: 221-228, 2005.
33. Rosines E, Johkura K, Zhang X, Schmidt HJ, Decambre M, Bush KT, Nigam S. Constructing kidney-like tissues from cells based on programs for organ development: towards a method of in vitro engineering of the kidney. Tissue Eng Part A 16: 2441-2455, 2010.
34. Sasaki S, Noda Y. Aquaporin-2 protein dynamics within the cell. Curr Opin Nephrol Hypertens 16: 348-352, 2007.
35. Sellers RS, Morton D, Michael B, Roome N, Johnson JK, Yano BL, Perry R, Schafer K. Society of Toxicologic Pathology position paper: organ weight recommendations for toxicology studies. Toxicol Pathol 35: 751-755, 2007.
36. Seo JY, Park J, Yu MR, Kim YS, Ha H, Lee HB. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes. Am J Nephrol 30: 481-490, 2009.
37. Shackelford C, Long G, Wolf J, Okerberg C, Herbert R. Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies. Toxicol Pathol 30: 93-96, 2002.
38. Singh P, Thomson SC. Renal homeostasis and tubuloglomerular feedback. Curr Opin Nephrol Hypertens 19: 59-64, 2010.
39. Takata K, Matsuzaki T, Tajika Y, Ablimit A, Hasegawa T. Localization and trafficking of aquaporin 2 in the kidney. Histochem Cell Biol 130: 197-209, 2008.
40. Tate SS, Meister A. gamma-Glutamyl transpeptidase from kidney. Methods Enzymol 113: 400-419, 1985.
41. Terryn S, Jouret F, Vandenabeele F, Smolders I, Moreels M, Devuyst O, Steels P, Van Kerkhove E. A primary culture of mouse proximal tubular cells, established on collagen-coated membranes. Am J Physiol Renal Physiol 293: F476-F485, 2007.
42. U.S. Renal Data System. Minneapolis, MN: U.S. Renal Data System, 2007.
43. Wu LL, Cox A, Roe CJ, Dziadek M, Cooper ME, Gilbert RE. Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system. Kidney Int 51: 1553-1567, 1997.
44. Yuen DA, Connelly KA, Advani A, Liao C, Kuliszewski MA, Trogadis J, Thai K, Advani SL, Zhang Y, Kelly DJ, Leong-Poi H, Keating A, Marsden PA, Stewart DJ, Gilbert RE. Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism. PLoS One 5: e9543, 2010.
45. Zeisberg M, Strutz F, Muller GA. Renal fibrosis: an update. Curr Opin Nephrol Hypertens 10: 315-320, 2001.
46. Zhai XY, Nielsen R, Birn H, Drumm K, Mildenberger S, Freudinger R, Moestrup SK, Verroust PJ, Christensen EI, Gekle M. Cubilin- and megalin-mediated uptake of albumin in cultured proximal tubule cells of opossum kidney. Kidney Int 58: 1523-1533, 2000.